Cargando…

Are phenylcarboxylic acids really markers in severe sepsis?

Detalles Bibliográficos
Autores principales:	Beloborodova, NV, Khodakova, AS, Olenin, AJ
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776214/ http://dx.doi.org/10.1186/cc8097

Ejemplares similares

Microbial metabolites in the blood of patients with sepsis
por: Khodakova, Anastasia, et al.
Publicado: (2007)

Effect of phenolic acids originating from microbes on mitochondria and neutrophils
por: Beloborodova, NV, et al.
Publicado: (2012)

Obesity and inflammatory markers in severe sepsis
por: Simon, P, et al.
Publicado: (2013)

Systemic symptoms as markers for severity in sepsis
por: Edman-Wallér, J, et al.
Publicado: (2015)

Severe asthma is really uncommon
por: Zicari, Anna Maria, et al.
Publicado: (2013)

Tyrosine metabolism disorder and the potential capability of anaerobic microbiota to decrease the value of aromatic metabolites in critically ill patients
por: Beloborodova, N, et al.
Publicado: (2014)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Base excess and arterial lactate as early prognostic markers in severe sepsis patients
por: Silva, JM, et al.
Publicado: (2005)

Effect of n-3 fatty acids on cerebral markers and the inflammatory response in sepsis
por: Burkhart, CS, et al.
Publicado: (2010)

Evaluation of procalcitonin as a diagnostic and prognostic marker in patients with sepsis, severe sepsis and septic shock associated with ventilator-associated pneumonia
por: Virtzili, S, et al.
Publicado: (2005)

A Study of Pro-Bnp Compared to Procalcitonin in Patient With Severe Sepsis As a Marker of Diagnosis of Sepsis in Critically Ill Patients
por: Elshrief, SR, et al.
Publicado: (2015)

High C-reactive protein and low cholesterol levels are prognostic marker in severe sepsis
por: Memis, D, et al.
Publicado: (2006)

Lactate as a prognostic marker in patients with severe sepsis or septic shock admitted to the ICU
por: Rocha, LL, et al.
Publicado: (2013)

Is hyperlactatemia a useful screening marker of severe sepsis in hemato-oncologic malignant patients?
por: Park, S, et al.
Publicado: (2015)

Is this admission really relevant?
por: Folkestad, Lars, et al.
Publicado: (2009)

Endocan can be a predictive marker of severity of sepsis but cannot be a marker of acute respiratory distress syndrome in ICU patients
por: Mizunuma, M, et al.
Publicado: (2015)

Relevance of eosinopenia as an early sepsis marker
por: Moura, EB, et al.
Publicado: (2011)

Nucleic acid amplification-based pathogen detection in the blood of severe sepsis patients
por: Bloos, Frank, et al.
Publicado: (2008)

0093. Mitochondrial function of immune cells in severe sepsis and septic shock - a prospective observational cohort study
por: Merz, TM, et al.
Publicado: (2014)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Impact of the Surviving Sepsis Campaign implementation on severe sepsis outcome
por: Silva, E
Publicado: (2011)

Costs of severe sepsis according to the guidelines of the 'Surviving Sepsis Campaign'
por: de Anda, G Vazquez, et al.
Publicado: (2005)

Epidemiology of severe sepsis in India
por: Chatterjee, S, et al.
Publicado: (2009)

Epidemiology of severe sepsis in India
por: Todi, S, et al.
Publicado: (2007)

Brain markers of neurodegeneration in sepsis survivor rats
por: de Souza Constantino, Larissa, et al.
Publicado: (2013)

Serum cholesterol level: is it a marker of sepsis?
por: Abraham, B, et al.
Publicado: (2005)

The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models
por: Shirakawa, K, et al.
Publicado: (2010)

Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
por: Gatserelia, Lana, et al.
Publicado: (2012)

New sepsis-related marker: endotoxin activity assay
por: Ikeda, T, et al.
Publicado: (2010)

Epidemiology of severe sepsis in India: an update
por: Todi, S, et al.
Publicado: (2010)

Tissue oxygenation in patients with severe sepsis
por: Oei, A, et al.
Publicado: (2014)

Is really epicardial fat a new marker of cardiovascular risk? A case-control cardiac magnetic resonance study
por: Igual-Muñoz, Begoña, et al.
Publicado: (2015)

Markers of endothelial dysfunction in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs. ringer's acetate
por: Müller, RB, et al.
Publicado: (2015)

Prognostic factors of severe sepsis: a result of Korean sepsis registry system
por: Chun, Byung-Chul, et al.
Publicado: (2008)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Immunonutrition with eicosapentaenoic acid and γ-linolenic acid as a new strategy to reduce mortality and improve outcomes in patients with severe sepsis
por: Pontes-Arruda, A, et al.
Publicado: (2006)

Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis in systemic inflammatory response syndrome
por: Shozushima, T, et al.
Publicado: (2011)

Effects of PPARγ in dendritic cells during severe sepsis and sepsis-induced immunosuppression
por: Molinaro, Raphael, et al.
Publicado: (2013)

Specific PKG inhibitors: do they really exist?
por: Gambaryan, Stepan, et al.
Publicado: (2011)

Decannulation: in the ICU or in the ward? Does it really matter?
por: Milercy, O, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rs8rs2n6g5i2q3jebov4apkpre